Rossari Biotech Ltd

Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rossari Biotech Ltd

₹ 469 0.21%
29 Apr 4:01 p.m.
rossari.com BSE: 543213 NSE: ROSSARI
About

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition

The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]

Key Points

Product Segments
The company is one of India’s leading specialty chemicals manufacturer offering 4,280+ products across 3 verticals: [1]

Website BSE NSE
  • Market Cap ₹ 2,603 Cr.
  • Current Price ₹ 469
  • High / Low ₹ 768 / 373
  • Stock P/E 17.4
  • Book Value ₹ 241
  • Dividend Yield 0.11 %
  • ROCE 14.6 %
  • ROE 11.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Company has a low return on equity of 12.4% over last 3 years.
  • Dividend payout has been low at 2.00% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
406 411 483 464 473 490 498 513 580 544 586 582 685
352 353 420 400 409 425 432 448 510 476 514 513 608
Operating Profit 55 58 64 64 64 65 66 65 69 68 72 69 77
OPM % 13% 14% 13% 14% 13% 13% 13% 13% 12% 12% 12% 12% 11%
3 2 1 4 1 1 1 1 2 2 2 1 20
Interest 4 6 5 4 3 4 4 5 6 6 6 8 9
Depreciation 16 14 15 15 16 15 15 18 18 18 18 20 24
Profit before tax 37 39 45 48 46 47 48 42 48 46 50 43 64
Tax % 22% 26% 26% 28% 25% 26% 27% 25% 28% 27% 26% 23% 28%
29 29 33 34 34 35 35 32 34 34 37 33 46
EPS in Rs 5.25 5.30 5.97 6.23 6.18 6.32 6.39 5.73 6.22 6.07 6.66 5.92 8.30
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
516 600 709 1,483 1,656 1,831 2,080 2,396
438 495 586 1,299 1,433 1,581 1,815 2,110
Operating Profit 78 105 124 184 223 250 265 286
OPM % 15% 17% 17% 12% 13% 14% 13% 12%
1 4 9 13 6 8 5 24
Interest 3 4 3 13 22 19 18 29
Depreciation 12 17 23 48 63 60 67 79
Profit before tax 63 88 107 136 144 178 185 203
Tax % 28% 26% 25% 28% 26% 26% 26% 26%
46 65 80 98 107 131 136 149
EPS in Rs 103.82 12.86 15.45 17.74 19.45 23.66 24.63 26.94
Dividend Payout % 0% 4% 3% 3% 3% 2% 2% 2%
Compounded Sales Growth
10 Years: %
5 Years: 28%
3 Years: 13%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 13%
3 Years: 12%
TTM: 9%
Stock Price CAGR
10 Years: %
5 Years: -18%
3 Years: -12%
1 Year: -31%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 12%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 10 10 11 11 11 11 11
Reserves 119 277 398 794 904 1,037 1,174 1,322
8 67 0 8 74 119 218 436
118 118 152 442 375 401 482 520
Total Liabilities 250 471 561 1,255 1,364 1,567 1,886 2,289
74 94 181 607 585 578 598 811
CWIP 3 22 0 1 16 47 140 173
Investments 0 18 0 36 51 63 84 35
173 338 379 611 712 880 1,063 1,269
Total Assets 250 471 561 1,255 1,364 1,567 1,886 2,289

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
71 57 48 29 152 43 137 65
-37 -190 -37 -299 -181 -103 -183 -219
-29 157 -25 292 61 16 65 186
Net Cash Flow 5 23 -14 22 32 -44 19 32
Free Cash Flow 27 -19 -8 -7 120 -83 -21 -175
CFO/OP 118% 74% 64% 43% 89% 39% 74% 47%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 61 57 74 75 78 85 83 85
Inventory Days 59 57 75 63 59 80 90 88
Days Payable 114 95 104 61 56 62 73 71
Cash Conversion Cycle 6 19 46 76 80 103 101 103
Working Capital Days 23 22 60 62 49 70 69 55
ROCE % 38% 29% 24% 18% 18% 16% 15%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Consolidated Installed Manufacturing Capacity
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Capacity Utilization (Group/Consolidated)
%
Number of Employees (Total Workforce)
Number
Export Share of Revenue
%
Number of Distributors
Number
Number of Products in Portfolio
Number
R&D Spend
INR Million
Core B2B Segment Volume Growth (YoY)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
68.44% 68.35% 68.34% 68.32% 68.32% 68.27% 68.19% 68.18% 68.18% 68.18% 68.15% 68.15%
6.12% 5.74% 4.14% 4.02% 3.83% 3.74% 3.74% 3.98% 3.48% 2.70% 2.32% 2.18%
17.71% 17.68% 18.06% 17.74% 16.87% 17.34% 17.47% 17.59% 17.84% 18.18% 18.25% 18.21%
7.73% 8.23% 9.45% 9.90% 10.98% 10.64% 10.60% 10.24% 10.50% 10.95% 11.25% 11.46%
No. of Shareholders 95,37195,2001,00,42398,8591,00,47597,18895,73592,85291,79191,38789,24986,972

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls